Biokine: BioLineRx Completes Recruitment into the Triple Combination Arm of the Motixafortide (BL-8040) COMBAT/KEYNOTE-202 Study in Metastatic Pancreatic Cancer – CBI

Homepage / Press Release / Biokine: BioLineRx Completes Recruitment into the Triple Combination Arm of the Motixafortide (BL-8040) COMBAT/KEYNOTE-202 Study in Metastatic Pancreatic Cancer

Press Release

Biokine: BioLineRx Completes Recruitment into the Triple Combination Arm of the Motixafortide (BL-8040) COMBAT/KEYNOTE-202 Study in Metastatic Pancreatic Cancer